Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
Corrigendum to 'Lack of factor VIII detection in humans and dogs with an intron 22 inversion challenges hypothesis regarding inhibitor risk' [Journal of Thrombosis and Haemostasis. Volume 22, Issue 12, December 2024, Pages 3415-3430].
Journal: Journal of thrombosis and haemostasis : JTH
Published: March 28, 2026
In Vitro Study of the Role of Factor IX in Treatment of Breakthrough Bleeds in Patients with Hemophilia A and Inhibitors Receiving Emicizumab.
Journal: TH open : companion journal to thrombosis and haemostasis
Published: November 13, 2025
Lack of factor VIII detection in humans and dogs with an intron 22 inversion challenges hypothesis regarding inhibitor risk.
Journal: Journal of thrombosis and haemostasis : JTH
Published: June 30, 2024
Efficacy and Safety of rVIII-SingleChain in Surgical Prophylaxis.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: December 01, 2023
Another Victory for Patients with Hemophilia.
Journal: The New England journal of medicine
Published: January 31, 2023
Hemophilia A: Strategies for Improving Long-Term Holistic Management, Adherence, and Quality of Life.
Journal: Journal of the advanced practitioner in oncology
Published: June 30, 2022
IDELVION: A Comprehensive Review of Clinical Trial and Real-World Data.
Journal: Journal of clinical medicine
Published: February 07, 2022
PERSEPT 3: A phase 3 clinical trial to evaluate the haemostatic efficacy of eptacog beta (recombinant human FVIIa) in perioperative care in subjects with haemophilia A or B with inhibitors.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: May 14, 2021
The safety of activated eptacog beta in the management of bleeding episodes and perioperative haemostasis in adult and paediatric haemophilia patients with inhibitors.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: April 13, 2021
B cell-activating factor modulates the factor VIII immune response in hemophilia A.
Journal: The Journal of clinical investigation
Published: July 31, 2020
Hemostatic effect of tranexamic acid combined with factor VIII concentrate in prophylactic setting in severe hemophilia A: A preclinical study.
Journal: Journal of thrombosis and haemostasis : JTH
Published: September 27, 2019
The evolution of factor VIIa in the treatment of bleeding in haemophilia with inhibitors.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: May 08, 2019
Last Updated: 09/26/2026